Navicixizumab Biosimilar - Anti-DLL4 and VEGFA mAb - Research Grade, Human Humanized, Monoclonal
Artikelnummer:
PTG-PX-TA1026-100
- Bilder (0)
| Artikelname: | Navicixizumab Biosimilar - Anti-DLL4 and VEGFA mAb - Research Grade, Human Humanized, Monoclonal |
| Artikelnummer: | PTG-PX-TA1026-100 |
| Hersteller Artikelnummer: | PX-TA1026-100 |
| Alternativnummer: | PTG-PX-TA1026-100 |
| Hersteller: | ProteoGenix |
| Wirt: | Human Humanized |
| Kategorie: | Antikörper |
| Spezies Reaktivität: | Human |
| Alternative Synonym: | Anti-DLL4, Anti-Delta4, Bispecific, OMP-305B83, CAS: 1638338-43-8 |
| Klonalität: | Monoclonal |
| UniProt: | Q9NR61 |
| Puffer: | 0.01M PBS, pH 7.4. |
| Expression System: | Eukaryotic expression |
| Target-Kategorie: | DLL4 & VEGFA |
Produktgarantie und fachkundiger Support
